Global vaccination efforts stall, leaving millions of children vulnerable to preventable diseases
LONDON (AP) — Efforts to vaccinate children globally have stalled since 2010, leaving millions vulnerable to tetanus, polio, tuberculosis and other diseases that can be easily prevented.
Protection from measles in particular dropped in 100 countries between 2010 and 2019, unravelling decades of progress, including in rich countries that had previously eliminated the highly infectious disease, according to a new analysis of global vaccination trends published Tuesday in the journal Lancet.
'After clean water, vaccination is the most effective intervention for protecting the health of our children,' said Helen Bedford, a professor of children's health at University College London, who was not connected to the research. She warned there has been a small but worrying rise in the number of parents skipping vaccination for their children in recent years, for reasons including misinformation.
In Britain, Bedford said that has resulted in the largest number of measles recorded since the 1990s and the deaths of nearly a dozen babies from whooping cough. Vaccination rates in the U.S. are also falling, and exemptions from vaccinations are at an all-time high.
After the World Health Organization established its routine immunization program in 1974, countries made significant efforts to protect children against preventable and sometimes fatal diseases; the program is credited with inoculating more than 4 billion children, saving the lives of 154 million worldwide.
Since the program began, the global coverage of children receiving three doses of the diphtheria-tetanus-whooping cough vaccine nearly doubled, from 40% to 81%. The percentage of kids getting the measles vaccine also jumped from 37% to 83%, with similar increases for polio and tuberculosis.
But after the COVID-19 pandemic, coverage rates dropped, with an estimated 15.6 million children missing out on the diphtheria-tetanus-whooping cough vaccine and the measles vaccine. Nearly 16 million children failed to get vaccinated against polio and 9 million missed out on the TB vaccine, with the biggest impact in sub-Saharan Africa. The study was funded by the Bill & Melinda Gates Foundation and Gavi, The Vaccine Alliance.
Researchers at the Institute for Health Metrics and Evaluation at the University of Washington, who conducted the analysis, noted that more than half of the world's 15.7 million unvaccinated children live in just eight countries in 2023: Nigeria, India, Congo, Ethiopia, Somalia, Sudan, Indonesia and Brazil.
Since President Trump has begun to withdraw the U.S. from the WHO and dismantled the U.S Agency for International Aid, public health experts have warned of new epidemics of infectious diseases. The researchers said it was too early to know what impact recent funding cuts might have on children's immunization rates.
The WHO said there had been an 11-fold spike in measles in the Americas this year compared to 2024. Measles infections doubled in the European region in 2024 versus the previous year and the disease remains common in Africa and Southeast Asia.
'It is in everyone's interest that this situation is rectified,' said Dr. David Elliman, a pediatrician who has advised the British government, in a statement. 'While vaccine-preventable infectious diseases occur anywhere in the world, we are all at risk.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Dr. Anosh Ahmed Expands National and International COVID Testing Operations with Renewed Emphasis on Compliance and Fraud Prevention
Dr. Anosh Ahmed expands COVID testing operations globally with renewed focus on compliance, contract integrity, and fraud prevention Chicago, Illinois, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces the expansion of his COVID-19 testing operations across the United States and internationally, building on his proven record of delivering high-quality testing services with a strong emphasis on COVID compliance and fraud prevention in testing. Dr. Anosh Ahmed As new COVID-19 variants continue to emerge, the demand for accurate and efficient testing remains high. Dr. Ahmed is securing new COVID testing contracts to serve municipal and state governments, large corporations, international health organizations, and critical infrastructure hubs such as ports and airports. Dr. Ahmed's team has already demonstrated operational excellence in major U.S. cities. In Chicago, Anosh Ahmed COVID testing programs have served frontline workers, underserved communities, and public housing residents. In Houston, Anosh Ahmed COVID testing efforts were recognized by Mayor Sylvester Turner after successfully delivering high-volume services during a key period of public health response. More on the Houston initiative can be found here: KHOU article. The expanded operations will feature a scalable model designed to deliver results quickly while maintaining full accuracy and compliance. International COVID testing efforts are also underway, with new agreements under negotiation in key global regions. Dr. Ahmed emphasizes transparency and integrity in all contracts. Measures in place include independent auditing, transparent digital tracking systems, full adherence to COVID compliance regulations at all levels, and leadership oversight dedicated to fraud prevention in testing. 'Given the scrutiny in this space, it is more important than ever to demonstrate accountability and public trust,' said Dr. Ahmed. 'Our team operates with zero tolerance for fraud or mismanagement. Every contract we fulfill is grounded in integrity and measurable outcomes.' As COVID testing contracts expand globally, Dr. Anosh Ahmed remains focused on restoring confidence in public health solutions and continuing to deliver trusted COVID testing services wherever needed. About Dr. Anosh Ahmed Dr. Anosh Ahmed is a Chicago-based physician, entrepreneur, and philanthropist known for leading trusted COVID-19 testing and vaccination programs across major U.S. cities and abroad. His ongoing work prioritizes COVID compliance, ethical standards, and fraud prevention in testing services. CONTACT: Meghan Trump Dr. Anosh Ahmed 312-588-8000 info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
36 minutes ago
- Medscape
Shifting the Narrative in Women's Health
Petra Simic, PhD AMSTERDAM, the Netherlands — When it comes to women's health, many people still think of 'breasts, uteruses, and hormones,' Petra Simic, PhD, a medical director at Bupa Health Clinics, said at HLTH Europe 2025 conference. But as clinicians, investors, and advocates made clear at the gathering, it is vastly more than that. The tide is slowly changing, fueled by data, technology, and a growing chorus of women's voices. Yet from diagnostics and research to clinical training and policy, systemic gaps remain. Acknowledging and actively closing these gaps is not just a matter of equality, it's a step toward better health outcomes for everyone, Anna Coates, PhD, a senior gender technical lead at the World Health Organization (WHO), told Medscape Medical News . Here Are Some Numbers The statistics around women's health remain shockingly grim, and their repetition might be a necessary reminder of the scale of the problem. Here are some numbers reported at the conference: Although women live longer than men, they spend 25% of their lives in greater illness and disability than men, which equates to an average of 9 years of poor health. Women are seven times more likely to be discriminated against by a healthcare provider. A woman is three times more likely than a man to be dismissed during a doctor's consultation. For the same disease, it can take a woman four times longer to receive a diagnosis. It takes an average of 6-10 years to diagnose a condition like endometriosis. A woman having a heart attack is seven times more likely to be dismissed and misdiagnosed in the emergency room and twice as likely to die as a result. While women constitute 70% of patients with chronic pain, 80% of pain medication research is conducted on men or male animals. Geography and income drastically alter outcomes. A woman diagnosed with breast cancer in a high-income country like Denmark has a 85%-90% 5-year survival rate. In India, that drops to around 60%, and in Nigeria, it is < 50%. In the US, a woman is now twice as likely to die in childbirth as her own mother was. Only 4% of venture capital investment in healthcare is directed toward women's health. Kristen Cerf Kristen Cerf, president and CEO at Blue Shield of California Promise Health Plan (PHP), pointed out that 'these statistics — every single one of them — worsen when talking about women of color.' These issues result in 75 million years of life lost due to poor health or early death annually. Closing the women's health gap could inject $1 trillion into the global economy by 2040. A Societal Problem Reflected in Healthcare These disparities are not solely a healthcare problem. Coates said that healthcare systems reflect broader society. 'If women are not generally valued, then we're going to see that replicated in the health system.' This isn't an external problem for medicine to point to, but rather one that it is an integral part of, she said. 'It's a societal problem, and you are part of that big society problem. So if the health system doesn't change, it's not playing its own role in that bigger societal change.' Moz Siddiqui 'It is a system's failure because mostly men have created that system," said Moz Siddiqui, a senior gender technical lead at the WHO Foundation. This systemic failure requires systemic stimuli to change. 'Systems don't change unless there are external stimuli,' said Cerf. But while moral arguments persist, many panelists agreed that financial and economic arguments are often more potent drivers. 'If the clinical and the patient perspective doesn't move governments, certainly the economics should move governments,' argued Tisha Boatman, who is responsible for external affairs and healthcare access at Siemens Healthineers. When the cost of misdiagnosis, lost productivity, and delayed treatment is quantified, the imperative to invest in women's health becomes undeniable, she said. Sleep: The Overlooked Pillar of Women's Health Tisha Boatman 'Sleep is really a core pillar of health, and it's just as important as nutrition, exercise, and stress resilience,' said Jennifer Kanady, PhD, director of sleep health technology at Samsung Electronics. Yet it is often the first thing to be sacrificed and the last to be addressed in clinical settings. Poor sleep is linked to increased risks for diabetes, heart disease, and dementia, and its patterns change significantly across a woman's life, influenced by menstrual cycles, pregnancy, and menopause. Insomnia, for example, might increase during pregnancy or the menopausal transition, but the causes and treatments might differ significantly depending on which of those phases a woman is in. This is where the diagnostic challenge becomes critical. A woman in perimenopause may visit her doctor complaining of fatigue and poor sleep. 'It might be diagnosed as insomnia, and the pattern is completely different,' said Ines Ramos Barreiras, EMEA regional medical advisor at Bayer. The root cause isn't a primary sleep disorder but a hormonal shift, meaning that a standard prescription for insomnia won't target the problem at its source. 'It's not only a problem of sleep, but how sleep is impacted,' she said. 'In menopause, women can go to sleep, but sleep is not as restoring as it needs to be.' Not a Smaller Man's Heart Cardiovascular disease is another space where a knowledge and awareness gap persists, both in the public domain and among healthcare practitioners. The public may not know the risks — Simic noted that a woman aged 45-65 years is 17 times more likely to die of cardiovascular disease than breast cancer — but the more critical gap is often with clinicians. 'We should stop treating the women's heart as a variation of the male heart,' said Michiel Winter, MD, a cardiologist at the Amsterdam University Medical Center who specializes in digital health. 'There's a very distinct difference. Risk factors like hypertension are much more harmful in women than in men, and it also means that they get different heart diseases, and that means different diagnostics and different therapy.' Even as technology advances, these old biases are being coded into new systems. 'Most algorithms are made for more male-specific cardiovascular disease,' Winter noted. For example, because the ST elevation in a female myocardial infarction is often less pronounced, 'the AI [artificial intelligence] algorithm picks up male STEMI (ST-elevation myocardial infarction) much more easily than it does for female.' Similarly, algorithms for interpreting ultrasounds are often better at identifying systolic heart failure (more common in men) than diastolic heart failure (more common in women). The Inevitable Transition Jocalyn Clark For too long, the narrative around menopause has been one of cessation and decline — a silent, private struggle marking the end of a woman's reproductive value. However, panelists at the HLTH Europe 2025 conference made clear that the story is being rewritten forcefully. What was once a taboo topic is now a 'menopause boom,' a global conversation fueled by a new generation of women demanding better information, care, and visibility, said Jocalyn Clark, the international editor at the British Medical Journal . 'When I came out of medical school, women disappeared from view of the health service at the age of 50 because they were postreproductive,' said Dame Lesley Regan, MD, a professor of obstetrics and gynecology at Imperial College London, London, England, and England's first Women's Health Ambassador. This perspective is dangerously outdated. With increasing lifespans, many women will now spend more of their lives postmenopausal than reproductive, she said. Dame Lesley Regan, MD The health risks that accelerate after menopause, such as cardiovascular disease and osteoporosis, are often overlooked in clinical consultations, often because healthcare professionals lack comprehensive menopause training, Regan said. In the UK, for example, general practitioners are no longer required to complete mandatory training in obstetrics and gynecology. Regan proposed that every healthcare professional — from orthopedic surgeons to cardiologists — should ask their female patients a simple question: 'Do you still have periods?' This, she argued, is a simple but important step to identifying women in the menopausal transition and ensuring their holistic health is considered. A New Narrative Bayo Curry-Winchell, MD The challenges are systemic, rooted in societal norms, and reflected in every corner of the healthcare industry. However, the collaboration between innovators, the commitment from advocates, and the increasing demand from patients are creating momentum, said Bayo Curry-Winchell, MD, a general practitioner in Reno, Nevada, and content creator. The solution lies in changing the narrative, she said. It requires normalizing conversations about menstruation, menopause, and every aspect of women's health. It means designing systems, products, and policies with women at the center. Most importantly, it involves listening to women from diverse backgrounds. As Ramos Barreiras said, there is a cultural expectation for women to be quiet. 'We don't complain. We were taught to be strong and to endure. And this is the shift we are seeking: to empower women to be vocal about what we want and the quality of life we deserve.' Simic is a medical director at Bupa Health Clinics; Cerf is the president and CEO at Blue Shield of California PHP; Boatman is responsible for external affairs and healthcare access at Siemens Healthineers; Kanady is the director of sleep health technology at Samsung Electronics; Ramos Barreiras is a EMEA Regional Medical Advisor at Bayer.
Los Angeles Times
39 minutes ago
- Los Angeles Times
Key GOP senator finally challenges RFK Jr.'s anti-vaccine policies — but he's too late
A physician, Sen. Bill Cassidy (R-La.) had long enjoyed bipartisan respect for his record of supporting child vaccinations. Indeed, as a doctor in Baton Rouge, he had personally played a role in getting hepatitis-B and flu vaccines into local schools. But Cassidy's reputation as a stalwart defender of public health crumbled on Feb. 4. That's when he took to the Senate floor to announce that he would vote to confirm the noted anti-vaccine activist Robert F. Kennedy Jr. as Secretary of Health and Human Services. Kennedy's nomination had hung by a thread while Cassidy's GOP colleagues waited to see how he would vote. His decision to confirm Kennedy put the nomination over the top when the confirmation vote was held on Feb. 13. Kennedy had assuaged Cassidy's doubts about him by promising that he and Cassidy would have 'an unprecedentedly close collaborative working relationship if he is confirmed,' Cassidy said. Among other promises, Kennedy pledged to maintain the key Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention 'without changes.' He even promised to give Cassidy, the chair of the Senate Committee on Health, Education, Labor and Pensions (HELP), the right to appoint a member on 'any board of commission formed to review vaccine safety.' It has since become clear that Kennedy thoroughly bamboozled Cassidy. On June 9, Kennedy fired all 17 members of ACIP and handpicked eight new members. The new cadre included 'antivaxxers, the antivax-adjacent, and the unqualified,' as veteran pseudoscience debunker David Gorski noted. None of them was nominated by Cassidy. Cassidy remained silent—until Monday, two days before the reconstituted ACIP is scheduled to hold its first two-day conference. In a post on X, Cassidy decried Kennedy's appointments. Many of them 'do not have significant experience studying microbiology, epidemiology or immunology,' he observed. 'In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them. (The mRNA vaccines are the COVID vaccines in global use marketed by Pfizer and Moderna.) Cassidy said the conference should be delayed until the panel is 'fully staffed with more robust and balanced representation—as required by law—including those with more direct relevant expertise.' It was Cassidy's first overt criticism of Kennedy's management of Health and Human Services, and long overdue. It wasn't entirely free of the pusillanimous approach he has taken thus far to Kennedy's regime, however. 'He asks for a delay until this committee is more 'balanced,' but 'balanced' in what way?' asks Paul Offit of Childrens Hospital of Philadelphia, one of the nation's most eminent vaccine experts (and a former ACIP member). 'Does that mean you have anti-vaccine activists and people who actually support the science? Does that mean you have an adequate balance of people who are good scientists and people who aren't?' There's also reason to wonder whether credible immunologists, epidemiologists and vaccinologists would even accept appointment to ACIP as long as anti-vaxxers are on the panel. 'I'm not sure many will be knocking down the door to sit with antiscience activists on the other side,' says Peter Hotez, a leading vaccine developer and expert. 'At this point the current committee needs to be dissolved.' Cassidy's reference to the law's requirement looks like something of a dodge. The law he refers to—the Federal Advisory Committee Act of 1982, or FACA — does require the membership of advisory committees to be 'fairly balanced in terms of the points of view represented.' But that doesn't require just any views about vaccines to be represented. 'That does not mean 'put science deniers on a vaccine advisory committee to represent the anti-science perspective,'' Dorit R. Reiss, an expert on vaccine law at UC College of the Law, told me. The committee's charter anticipates that the members will have varied expertise in different vaccines and vaccine-preventable diseases: 'It's not a violation of FACA to not appoint anti-vaccine activists,' she says. A spokesman for Kennedy didn't respond to my request for comment on Cassidy's statement. As of this writing, it's still scheduled to convene Wednesday morning and continue Thursday with the eight members Kennedy appointed. A final agenda posted Tuesday lists a presentation by Lyn Redwood on thimerosal in vaccines. The item was not present on earlier agenda drafts. Thimerosol is a preservative previously used in vaccines that long has been a target of anti-vaccine activists who asserted that it caused autism in children given the shots; that claim has been decisively debunked. Redwood is a former president of Children's Health Defense, an anti-vaccine organization long associated with Kennedy. Its resurrection as an agenda item suggests that Kennedy has not given up on the debunked claim that vaccines and autism are linked. I asked Cassidy to expand on his tweet, but a spokesman told me he wouldn't have anything to say beyond that. When I asked earlier whether Cassidy thought he had been deceived when Kennedy reneged on his pledge to keep ACIP functioning 'without changes,' his spokesman replied that Kennedy's commitment 'was about the ACIP process, not staffing.' That's not at all how Cassidy described Kennedy's commitment on Feb. 4. ACIP's recommendations on vaccine use don't become law until they're accepted by the head of the CDC. At this moment, however, the CDC doesn't have a director. Donald Trump withdrew his first nominee for the post, former Republican Congressman Dave Weldon of Florida, after the emergence of his anti-vaccination views, including his support for the long-debunked claim that the MMR vaccine causes autism—a view also espoused by Kennedy. Donald Trump subsequently nominated Susan Monarez, who is currently the agency's acting director, but she hasn't been confirmed by the Senate. Monarez holds a doctorate in microbiology but would be the first CDC director since 1953 not to have a medical degree. The vacuum atop the CDC facilitated Kennedy's unilateral decision to take the COVID vaccines off the recommended list for pregnant women and healthy children, which ran counter to the position of the larger medical community. It doesn't seem likely that Cassidy's modest pushback against Kennedy's evisceration of ACIP will restore his standing as the Senate's go-to authority on vaccines and public health, given the deference he showed to Kennedy up to now. 'I don't think he can do anything,,' Offit told me. 'His moment came when he voted 'yes'' on Kennedy's confirmation. 'Cassidy keeps drawing lines, RFK Jr. crosses them, and he draws another line, and another line. He said that RFK Jr. promised he wouldn't change existing recommendations, and that's just what he did, for pregnant people and young children for the COVID vaccine. He said he wouldn't alter the [ACIP] panel, and that's exactly what he did. Worse, he brought people on who don't have the expertise to give us the kind of advice we need.' Even if Kennedy takes Cassidy's advice and postpones the ACIP meeting to give the membership 'balance,' the damage to its authority will be lasting. 'The entire medical and scientific community will now reject the ACIP—and for that matter, the CDC—as a source of information,' Offit says. 'That's what Cassidy has done while standing back and letting all this happen.' Kennedy has plunged ACIP and the CDC into a partisan and ideological morass. 'Until Kennedy, this was a non-political expert committee,' says Reiss. 'He is reshaping it to promote an anti-vaccine agenda, and likely in an effort to deny people vaccines.' Thanks to Kennedy, America's once-vaunted expertise in public health has been infected with the anti-science virus. For that virus, there doesn't appear to be a vaccine on the horizon.
